Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Forget about the car keys, do you know when to take away your parent's checkbook?

  • Follow-up on psychiatric disorders in young people after release from detention

  • Teens with a history of TBI are nearly 4 times more likely to have used crystal meth

  • Stroke damage mechanism identified

  • Drug to reduce side-effects of 'binge drinking' developed

  • How do Tourette's patients react to visual stimulation with their own self-image?

  • 'Trigger' for stress processes discovered in brain

  • New research supporting stroke rehabilitation

  • Mindfulness treatment as effective as CBT for depression, anxiety

  • Fragile X study offers hope of new autism treatment

  •